AIM: To investigate the serum levels of prorenin and its correlation with the severity of diabetic retinopathy (DR). METHODS: 248 patients with diabetes and 108 control subjects were divided into four groups: no-DR (n = 146), no proliferative diabetic retinopathy (no-PDR) (n = 78), PDR (n = 24), and controls (n = 108). Serum levels of prorenin from all subjects were measured using the new antibody activating direct kinetic (AAD-PR) assay. The serum prorenin levels were compared among the groups. RESULTS: The serum levels of prorenin in the control, no-DR, no-PDR, and PDR groups, respectively, were 109.1 (66.1), 194.6 (160.4), 271.5 (220.3), and 428.4 (358.4) pg/ml (mean (SD)). Prorenin in the PDR group was remarkably high compared with the control and no-DR groups (p<0.0001) and with the no-PDR group (p = 0.002). Serum levels of prorenin increased with increasingly severe retinopathy. No correlation was found between the prorenin level and the duration of disease or HbA(1c). CONCLUSIONS: The serum levels of prorenin in patients with PDR were found to be markedly high using the AAD-PR assay. Increased levels of prorenin in diabetes may have an important role in the pathogenesis of DR.
AIM: To investigate the serum levels of prorenin and its correlation with the severity of diabetic retinopathy (DR). METHODS: 248 patients with diabetes and 108 control subjects were divided into four groups: no-DR (n = 146), no proliferative diabetic retinopathy (no-PDR) (n = 78), PDR (n = 24), and controls (n = 108). Serum levels of prorenin from all subjects were measured using the new antibody activating direct kinetic (AAD-PR) assay. The serum prorenin levels were compared among the groups. RESULTS: The serum levels of prorenin in the control, no-DR, no-PDR, and PDR groups, respectively, were 109.1 (66.1), 194.6 (160.4), 271.5 (220.3), and 428.4 (358.4) pg/ml (mean (SD)). Prorenin in the PDR group was remarkably high compared with the control and no-DR groups (p<0.0001) and with the no-PDR group (p = 0.002). Serum levels of prorenin increased with increasingly severe retinopathy. No correlation was found between the prorenin level and the duration of disease or HbA(1c). CONCLUSIONS: The serum levels of prorenin in patients with PDR were found to be markedly high using the AAD-PR assay. Increased levels of prorenin in diabetes may have an important role in the pathogenesis of DR.
Authors: F Suzuki; Y Hatano; T Nakagawa; K Terazawa; A Gotoh; U M Nasir; Y Ishida; Y Nakamura Journal: Biosci Biotechnol Biochem Date: 1999-03 Impact factor: 2.043
Authors: M B Mattock; N Cronin; P Cavallo-Perin; B Idzior-Walus; G Penno; S Bandinelli; E Standl; A Kofinis; J H Fuller Journal: Diabet Med Date: 2001-01 Impact factor: 4.359
Authors: N Chaturvedi; A K Sjoelie; M Porta; S J Aldington; J H Fuller; M Songini; E M Kohner Journal: Diabetes Care Date: 2001-02 Impact factor: 19.112
Authors: Monique E Cho; Carol Sweeney; Nora Fino; Tom Greene; Nirupama Ramkumar; Yufeng Huang; Ana C Ricardo; Tariq Shafi; Rajat Deo; Amanda Anderson; Katherine T Mills; Alfred K Cheung Journal: Am J Nephrol Date: 2021-03-18 Impact factor: 3.754